美国FDA授予Nomacopan治疗大疱性类天疱疮的孤儿药物指定

2019-09-15 Allan MedSci原创

Akari Therapeutics是一家生物制药公司,专注于开发自身免疫和炎症性疾病的创新疗法,主要涉及补体(C5)和/或白三烯(LTB4)系统。Akari近日宣布美国FDA已批准其nomacopan治疗大疱性类天疱疮(BP)的孤儿药物指定。

Akari Therapeutics是一家生物制药公司,专注于开发自身免疫和炎症性疾病的创新疗法,主要涉及补体(C5)和/或白三烯(LTB4)系统。Akari近日宣布美国FDA已批准其nomacopan治疗大疱性类天疱疮(BP)的孤儿药物指定。

Akari Therapeutics的首席执行官Clive Richardson说:“BP是一种严重起泡的皮肤状况,尚无经过批准的疗法。它也是一种由于人口老龄化和诊断改善而导致患病率增加的疾病。nopcopan的孤儿药物指定是该项目向前迈出的重要一步。该公司计划于20191010日在第28届欧洲皮肤病学和性病学会(EADV)大会上由Christian Sadik博士口头介绍nomacopan的最新进展。


原始出处:

http://www.firstwordpharma.com/node/1666168#axzz5zU18ApSM

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1996314, encodeId=ff0d199631470, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Wed Apr 08 13:38:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693959, encodeId=515216939593d, content=<a href='/topic/show?id=63391292887' target=_blank style='color:#2F92EE;'>#Nomacopan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12928, encryptionId=63391292887, topicName=Nomacopan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5e29506044, createdName=yankaienglish, createdTime=Mon Mar 02 03:38:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740112, encodeId=3b8d1e4011270, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45431, encryptionId=f5a445431df, topicName=孤儿药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f034650217, createdName=ms6980045490879608, createdTime=Mon Sep 30 05:38:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775159, encodeId=2c641e7515904, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43789, encryptionId=c56f43e89eb, topicName=大疱性类天疱疮)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc0e38759441, createdName=freve, createdTime=Tue Jul 28 12:38:00 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740157, encodeId=38891e4015712, content=<a href='/topic/show?id=99f2454322e' target=_blank style='color:#2F92EE;'>#孤儿药物指定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45432, encryptionId=99f2454322e, topicName=孤儿药物指定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d3d34654584, createdName=12498b37m83暂无昵称, createdTime=Thu Jun 11 14:38:00 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551446, encodeId=79fa15514462a, content=<a href='/topic/show?id=5d84e9716c0' target=_blank style='color:#2F92EE;'>#美国FDA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79716, encryptionId=5d84e9716c0, topicName=美国FDA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a46914191431, createdName=10518098zz, createdTime=Tue Sep 17 00:38:00 CST 2019, time=2019-09-17, status=1, ipAttribution=)]
    2020-04-08 yb6560
  2. [GetPortalCommentsPageByObjectIdResponse(id=1996314, encodeId=ff0d199631470, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Wed Apr 08 13:38:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693959, encodeId=515216939593d, content=<a href='/topic/show?id=63391292887' target=_blank style='color:#2F92EE;'>#Nomacopan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12928, encryptionId=63391292887, topicName=Nomacopan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5e29506044, createdName=yankaienglish, createdTime=Mon Mar 02 03:38:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740112, encodeId=3b8d1e4011270, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45431, encryptionId=f5a445431df, topicName=孤儿药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f034650217, createdName=ms6980045490879608, createdTime=Mon Sep 30 05:38:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775159, encodeId=2c641e7515904, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43789, encryptionId=c56f43e89eb, topicName=大疱性类天疱疮)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc0e38759441, createdName=freve, createdTime=Tue Jul 28 12:38:00 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740157, encodeId=38891e4015712, content=<a href='/topic/show?id=99f2454322e' target=_blank style='color:#2F92EE;'>#孤儿药物指定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45432, encryptionId=99f2454322e, topicName=孤儿药物指定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d3d34654584, createdName=12498b37m83暂无昵称, createdTime=Thu Jun 11 14:38:00 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551446, encodeId=79fa15514462a, content=<a href='/topic/show?id=5d84e9716c0' target=_blank style='color:#2F92EE;'>#美国FDA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79716, encryptionId=5d84e9716c0, topicName=美国FDA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a46914191431, createdName=10518098zz, createdTime=Tue Sep 17 00:38:00 CST 2019, time=2019-09-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1996314, encodeId=ff0d199631470, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Wed Apr 08 13:38:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693959, encodeId=515216939593d, content=<a href='/topic/show?id=63391292887' target=_blank style='color:#2F92EE;'>#Nomacopan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12928, encryptionId=63391292887, topicName=Nomacopan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5e29506044, createdName=yankaienglish, createdTime=Mon Mar 02 03:38:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740112, encodeId=3b8d1e4011270, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45431, encryptionId=f5a445431df, topicName=孤儿药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f034650217, createdName=ms6980045490879608, createdTime=Mon Sep 30 05:38:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775159, encodeId=2c641e7515904, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43789, encryptionId=c56f43e89eb, topicName=大疱性类天疱疮)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc0e38759441, createdName=freve, createdTime=Tue Jul 28 12:38:00 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740157, encodeId=38891e4015712, content=<a href='/topic/show?id=99f2454322e' target=_blank style='color:#2F92EE;'>#孤儿药物指定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45432, encryptionId=99f2454322e, topicName=孤儿药物指定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d3d34654584, createdName=12498b37m83暂无昵称, createdTime=Thu Jun 11 14:38:00 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551446, encodeId=79fa15514462a, content=<a href='/topic/show?id=5d84e9716c0' target=_blank style='color:#2F92EE;'>#美国FDA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79716, encryptionId=5d84e9716c0, topicName=美国FDA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a46914191431, createdName=10518098zz, createdTime=Tue Sep 17 00:38:00 CST 2019, time=2019-09-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1996314, encodeId=ff0d199631470, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Wed Apr 08 13:38:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693959, encodeId=515216939593d, content=<a href='/topic/show?id=63391292887' target=_blank style='color:#2F92EE;'>#Nomacopan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12928, encryptionId=63391292887, topicName=Nomacopan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5e29506044, createdName=yankaienglish, createdTime=Mon Mar 02 03:38:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740112, encodeId=3b8d1e4011270, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45431, encryptionId=f5a445431df, topicName=孤儿药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f034650217, createdName=ms6980045490879608, createdTime=Mon Sep 30 05:38:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775159, encodeId=2c641e7515904, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43789, encryptionId=c56f43e89eb, topicName=大疱性类天疱疮)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc0e38759441, createdName=freve, createdTime=Tue Jul 28 12:38:00 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740157, encodeId=38891e4015712, content=<a href='/topic/show?id=99f2454322e' target=_blank style='color:#2F92EE;'>#孤儿药物指定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45432, encryptionId=99f2454322e, topicName=孤儿药物指定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d3d34654584, createdName=12498b37m83暂无昵称, createdTime=Thu Jun 11 14:38:00 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551446, encodeId=79fa15514462a, content=<a href='/topic/show?id=5d84e9716c0' target=_blank style='color:#2F92EE;'>#美国FDA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79716, encryptionId=5d84e9716c0, topicName=美国FDA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a46914191431, createdName=10518098zz, createdTime=Tue Sep 17 00:38:00 CST 2019, time=2019-09-17, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1996314, encodeId=ff0d199631470, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Wed Apr 08 13:38:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693959, encodeId=515216939593d, content=<a href='/topic/show?id=63391292887' target=_blank style='color:#2F92EE;'>#Nomacopan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12928, encryptionId=63391292887, topicName=Nomacopan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5e29506044, createdName=yankaienglish, createdTime=Mon Mar 02 03:38:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740112, encodeId=3b8d1e4011270, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45431, encryptionId=f5a445431df, topicName=孤儿药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f034650217, createdName=ms6980045490879608, createdTime=Mon Sep 30 05:38:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775159, encodeId=2c641e7515904, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43789, encryptionId=c56f43e89eb, topicName=大疱性类天疱疮)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc0e38759441, createdName=freve, createdTime=Tue Jul 28 12:38:00 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740157, encodeId=38891e4015712, content=<a href='/topic/show?id=99f2454322e' target=_blank style='color:#2F92EE;'>#孤儿药物指定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45432, encryptionId=99f2454322e, topicName=孤儿药物指定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d3d34654584, createdName=12498b37m83暂无昵称, createdTime=Thu Jun 11 14:38:00 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551446, encodeId=79fa15514462a, content=<a href='/topic/show?id=5d84e9716c0' target=_blank style='color:#2F92EE;'>#美国FDA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79716, encryptionId=5d84e9716c0, topicName=美国FDA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a46914191431, createdName=10518098zz, createdTime=Tue Sep 17 00:38:00 CST 2019, time=2019-09-17, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1996314, encodeId=ff0d199631470, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Wed Apr 08 13:38:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693959, encodeId=515216939593d, content=<a href='/topic/show?id=63391292887' target=_blank style='color:#2F92EE;'>#Nomacopan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12928, encryptionId=63391292887, topicName=Nomacopan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd5e29506044, createdName=yankaienglish, createdTime=Mon Mar 02 03:38:00 CST 2020, time=2020-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740112, encodeId=3b8d1e4011270, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45431, encryptionId=f5a445431df, topicName=孤儿药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f034650217, createdName=ms6980045490879608, createdTime=Mon Sep 30 05:38:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775159, encodeId=2c641e7515904, content=<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大疱性类天疱疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43789, encryptionId=c56f43e89eb, topicName=大疱性类天疱疮)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc0e38759441, createdName=freve, createdTime=Tue Jul 28 12:38:00 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1740157, encodeId=38891e4015712, content=<a href='/topic/show?id=99f2454322e' target=_blank style='color:#2F92EE;'>#孤儿药物指定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45432, encryptionId=99f2454322e, topicName=孤儿药物指定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d3d34654584, createdName=12498b37m83暂无昵称, createdTime=Thu Jun 11 14:38:00 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551446, encodeId=79fa15514462a, content=<a href='/topic/show?id=5d84e9716c0' target=_blank style='color:#2F92EE;'>#美国FDA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79716, encryptionId=5d84e9716c0, topicName=美国FDA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a46914191431, createdName=10518098zz, createdTime=Tue Sep 17 00:38:00 CST 2019, time=2019-09-17, status=1, ipAttribution=)]

相关资讯

Akari的补体抑制剂nomacopan治疗造血干细胞移植相关血栓性微血管病变,获得FDA的孤儿药指定

Akari Therapeutics的研究性药物nomacopan(Coversin)治疗造血干细胞移植相关血栓性微血管病变(HSCT-TMA)获得FDA的孤儿药指定,该消息促使Akari公司股票上周五上涨了13%。

Akari的补体抑制剂Nomacopan治疗小儿造血干细胞移植相关血栓性微血管病,获得FDA快速通道指定

Akari Therapeutics宣布其nomacopan治疗造血干细胞移植相关血栓性微血管病(HSCT-TMA)儿科患者,喜获美国食品和药物管理局(FDA)的快速通道指定。